OIRA Conclusion of EO 12866 Regulatory Review


RIN: 0910-ZA76         View EO 12866 Meetings Received Date: 07/22/2020 
Title: Cannabidiol Enforcement Policy; Draft Guidance for Industry; Availability  
Agency/Subagency: HHS / FDA  
Concluded Action: Withdrawn  Concluded Date: 01/21/2021 
Publication Date:  
Regulatory Flexibility Analysis Required: No  Small Entities Affected: No 
Federalism Implications: No  Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No